Pheno.AI
Phenotype Multi-omics Datasets to Improve Human Health
Company Overview
Snapshot
Founded in March 2021 by Ori Cohen, Pheno.AI operates with 11–50 employees. The company has secured funding across two rounds from Entrée Capital and Corundum Neuroscience. In November 2024, Pheno.AI, in collaboration with the Weizmann Institute of Science and NVIDIA, developed GluFormer, an AI model to predict future glucose levels and other health metrics.
Business overview
Pheno.AI is dedicated to advancing human health by curating and providing access to extensive deep-phenotype multi-omics datasets. Its core offering is a secure workspace that enables collaboration and adjustable compute resources for research, built upon data collected from the Human Phenotype Project's 25-year longitudinal study. The company operates within the Health Tech & Life Sciences sector, focusing on digital healthcare and medical decision support, serving markets such as biotechnology, pharmaceuticals, laboratories, and healthcare providers.
Strategic signal
In November 2024, Pheno.AI partnered with the Weizmann Institute of Science and NVIDIA to develop GluFormer, an AI model capable of predicting future glucose levels and other health metrics. This collaboration signals a significant advancement in personalized medicine and predictive analytics, offering pharmaceutical companies a tool to forecast clinical trial outcomes and tailor patient treatment plans, thereby enhancing the company's position in AI-driven health solutions.
Log in to access full profile ›Company Intelligence Q&A
- What is Pheno.AI's primary mission?
- Pheno.AI's mission is to improve human health by collecting, organizing, and making accessible the world's largest collection of deep-phenotype multi-omics datasets, enabling other researchers to utilize this data.
- What significant AI model did Pheno.AI recently develop?
- In November 2024, Pheno.AI, in collaboration with the Weizmann Institute of Science and NVIDIA, developed GluFormer, an AI model designed to predict future glucose levels and other health metrics based on past data.
- Which project provides the data for Pheno.AI's datasets?
- The datasets utilized by Pheno.AI were collected as part of the Human Phenotype Project, a global effort that launched in 2018 and has enrolled 20,000 participants to date for a 25-year longitudinal study.
- When was Pheno.AI founded and by whom?
- Pheno.AI was founded in March 2021 by Ori Cohen.
- Which investor participated in Pheno.AI's June 2022 funding round?
- In June 2022, Pheno.AI received Seed funding from Entrée Capital, which led the round.